Rosenblum Mark J 4
4 · Salarius Pharmaceuticals, Inc. · Filed Jan 21, 2022
Insider Transaction Report
Form 4
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
- Award
Stock Option (right to buy)
2022-01-20+200,000→ 200,000 totalExercise: $0.48Exp: 2032-01-19→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]25% of the options are fully vested on January 19, 2023, and 1/36 of the remaining options vest on each monthly anniversary thereafter.